Salih Sanlioglu

12PUBLICATIONS
6CO-AUTHORS
Neurology and neuromuscular diseasesWastewater treatment processesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Agricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 23, 2026
Spinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease.

|Jun 11, 2026
Lentiviral GLP-1 gene therapy elicits developmental stage-dependent β-cell regeneration in diabetic rats.

|May 15, 2026
A Comprehensive Evaluation of CAR-T Cell Gene Therapy, Tracing its Revolutionary Clinical Breakthroughs and Advancements Towards Next-Generation Engineering.

|Apr 25, 2026
Advances in CRISPR Base Editing: From Molecular Evolution to Therapeutic Applications in Genomic Medicine.

|Mar 19, 2026
An Ad5-Based COVID-19 Vaccine Encoding SARS-CoV-2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice.

Fulya Erendor, Fatih Uzer, Salih Sanlioglu

|Nov 11, 2025
Lantidra (donislecel) in type 1 diabetes: An in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy.

Ezgi Erbasan, Melike Aliciaslan, Fulya Erendor

Pageof 2

Frequent Collaborators

3 joint publications

Fulya Erendor

3 joint publications

Melike Aliciaslan

3 joint publications

Ezgi Erbasan

2 joint publications

Busra Cetin